Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer
Open Access
- 9 October 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (36) , 38866-38880
Abstract
Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancerKeywords
This publication has 53 references indexed in Scilit:
- Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptorJournal of Oral Pathology & Medicine, 2013
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell CarcinomaPLOS ONE, 2011
- Transduction of Tumor-Specific T Cells with CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune ResponsesClinical Cancer Research, 2010
- Pro-inflammatory Genes as Biomarkers and Therapeutic Targets in Oral Squamous Cell CarcinomaJournal of Biological Chemistry, 2010
- Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral CancerCancer Prevention Research, 2010
- Understanding resistance to EGFR inhibitors—impact on future treatment strategiesNature Reviews Clinical Oncology, 2010
- The InflammasomesCell, 2010
- The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesisNature Immunology, 2009
- Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisBMC Cancer, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008